OR WAIT null SECS
June 19, 2018
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
June 18, 2018
Intelligent manufacturing and environmental policies are key trends at P-MEC 2018.
June 14, 2018
Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
June 13, 2018
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
June 08, 2018
MilliporeSigma targets emerging biotechs with US development center and global grants.
June 07, 2018
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
June 05, 2018
The agency has approved Mylan’s Fulphila (pegfilgrastim-jmdb) as the first US-approved biosimilar to Amgen’s Neulasta (pegfilgrastim) to reduce infection risk during cancer treatment.